Back to the journal

Peptides

Epitalon acetate and intermittent courses

Epitalon acetate and intermittent courses

4 min read

Short answer. The policy describes enforcement discretion for epitalon acetate as a subcutaneous or intramuscular injection, dispensed in intermittent courses, from an ingredient with a qualifying certificate of analysis [2]. It does not print a dose or a calendar. It does not say epitalon lengthens life. As of Oct 29, 2026.

The peptide it names

Appendix B prints epitalon acetate as molecular formula C14H22N4O9·CH3COOH, molecular weight 450.40 g/mol, sequence H-Ala-Glu-Asp-Gly-OH as the acetate [2]. Four amino acids.

Same pattern as the others. Category 2 from September 29, 2023 until April 22, 2026 did not change 503A status. CDER recommended against listing. The advisory committee voted to include it [2]. The notice still says nothing was added to the 503A bulks list by this policy, and compounded drugs are not FDA-approved [1].

Intermittent is a limit, not a schedule

HHS says the documented regimens it relied on are intermittent rather than continuous, and that limited controlled human exposure reported no side effects [2]. That is HHS characterizing the record it used. It is not a regimen for you to copy. The policy does not list days, milligrams, or cycles. Anyone who fills those blanks and calls them "the HHS protocol" is ahead of the document.

The epitalon evidence page still says a telomere finding does not prove longer life. The Oct 28 policy does not revise that sentence. Immune-reaction and theoretical cancer questions in the FDA briefing are not answered by an enforcement policy.

Sommar Club does not prescribe or sell epitalon.

FAQ

What is an intermittent course? The policy uses those words as a limit on how the acetate injection is dispensed [2]. It does not define a schedule in the text we used for this page.

Is epitalon a longevity drug now? No. The notice approves nothing [1].

Sources

  1. HHS notice, FR Doc. 2026-22192, filed Oct 28, 2026. https://public-inspection.federalregister.gov/2026-22192.pdf

  2. HHS policy, Appendix B, epitalon. https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf

Education only. Not medical or legal advice. As of Oct 29, 2026.

Three minutes tonight.

Answer a few questions. Hear back from a clinician, usually within a day.

See if you qualifyFree online visit. Pay nothing unless approved.
Sommar Club NAD+ editorial product conceptNAD+
Sommar Club GLP-1 CARE editorial product conceptGLP-1 CARE
Sommar Club SERMORELIN editorial product conceptSERMORELIN